Opsumit 10MG-QTY 2 @ 6,270.03 december order - $12,540.06
Ended Awarded Last action
- Contract number
- 15B50526F00000025
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $12,540
Award facts
- Contract value 100% obligated
- $12,540.06 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Titusville, Hopewell Township, NJ 08560, USA
Award details come from SAM.gov/FPDS.
About this award
Actelion Pharmaceuticals US, Inc. has been awarded a firm fixed-price delivery order valued at $12,540.06 for the procurement of Opsumit 10mg (2 units at $6,270.03 each) in December 2025. The award was made by the Federal Medical Center Carswell, a civilian healthcare facility, with the product to be delivered to Titusville, Hopewell Township, New Jersey. This delivery order carries no small business set-aside designation and represents a direct pharmaceutical procurement under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which is valued at approximately $219.1 million through July 2029.
This award exemplifies Actelion's established role as a critical supplier of specialized pharmaceutical treatments to federal healthcare institutions. Opsumit, a pulmonary arterial hypertension medication, is among the company's core product offerings to the federal government, with the company holding multiple indefinite delivery vehicles including two blanket purchase agreements valued at $118.5 million and $83.5 million respectively. The Federal Medical Center Carswell's procurement through this delivery order reflects the ongoing demand for rare disease treatments within the federal correctional healthcare system, enabling the facility to provide essential medications to its eligible beneficiaries through pre-negotiated pricing mechanisms.
Quick answers
Who was awarded contract 15B50526F00000025?
15B50526F00000025 was awarded to Actelion Pharmaceuticals US, Inc. by Federal Medical Center Carswell (Correctional Facilities) on December 31, 2025.
How much is contract 15B50526F00000025 worth?
The government has obligated $12,540 on 15B50526F00000025.
Is contract 15B50526F00000025 an order under another contract?
Yes. 15B50526F00000025 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000025 competed?
The extent of competition for 15B50526F00000025 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award